Depletion of Ppp6c in hematopoietic and vascular endothelial cells causes embryonic lethality and decreased hematopoietic potential
Experimental Hematology · 2024
DOI: 10.1016/j.exphem.2024.104205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology, 2024. Verfasst von Ayumi Kondo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science, Graduate School of Humanities and Sciences, Nara Women's University, Nara, Japan. Hauptthemen laut MEDLINE: Hematopoiesis, Phosphoprotein Phosphatases. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Kansai Medical University, Japan Science and Technology Agency.
Abstract (Originalsprache)
Protein phosphatase 6 (PP6) is a serine/threonine (Ser/Thr) protein phosphatase, and its catalytic subunit is Ppp6c. PP6 forms the PP2A subfamily with PP2A and PP4. The diverse phenotypes observed following small interfering RNA (siRNA)-based knockdown of Ppp6c in cultured mammalian cells suggest that PP6 plays roles in cell growth and DNA repair. There is also evidence that PP6 regulates nuclear factor kappa B (NF-κB) signaling and mitogen-activated protein kinases and inactivates transforming growth factor-β-activated kinase 1 (TAK1). Loss of Ppp6c causes several abnormalities, including those of T cell and regulatory T cell function, neurogenesis, oogenesis, and spermatogenesis. PP2A has been reported to play an important role in erythropoiesis. However, the roles of PP6 in other hematopoietic cells have not been investigated. We generated Ppp6cfl/fl;Tie2-Cre (Ppp6cTKO) mice, in which Ppp6c was specifically deleted in hematopoietic and vascular endothelial cells. Ppp6cTKO mice displayed embryonic lethality. Ppp6c deficiency increased the number of dead cells and decreased the percentages of erythroid and monocytic cells during fetal hematopoiesis. By contrast, the number of Lin-Sca-1+c-Kit+ cells, which give rise to all hematopoietic cells, was slightly increased, but their colony-forming cell activity was markedly decreased. Ppp6c deficiency also increased phosphorylation of extracellular signal-regulated kinase 1/2 and c-Jun amino (N)-terminal kinase in fetal liver hematopoietic cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Science, Graduate School of Humanities and Sciences, Nara Women's University, Nara, Japan.
- Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
- Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi, Japan.
- Department of Biological Science, Graduate School of Humanities and Sciences, Nara Women's University, Nara, Japan. Electronic address: toshiwatana@cc.nara-wu.ac.jp.
Förderung
- Japan Society for the Promotion of Science
- Kansai Medical University
- Japan Science and Technology Agency
Zitieren
APA
Kondo, A., Tanaka, H., Rai, S., Shima, H., Matsumura, I., & Watanabe, T. (2024). Depletion of Ppp6c in hematopoietic and vascular endothelial cells causes embryonic lethality and decreased hematopoietic potential. Experimental Hematology. https://doi.org/10.1016/j.exphem.2024.104205
Vancouver
Kondo A, Tanaka H, Rai S, Shima H, Matsumura I, Watanabe T. Depletion of Ppp6c in hematopoietic and vascular endothelial cells causes embryonic lethality and decreased hematopoietic potential. Experimental Hematology. 2024. doi:10.1016/j.exphem.2024.104205
BibTeX
@article{Kondo2024,
author = {Kondo, Ayumi and Tanaka, Hirokazu and Rai, Shinya and Shima, Hiroshi and Matsumura, Itaru and Watanabe, Toshio},
title = {Depletion of Ppp6c in hematopoietic and vascular endothelial cells causes embryonic lethality and decreased hematopoietic potential},
journal = {Experimental Hematology},
year = {2024},
doi = {10.1016/j.exphem.2024.104205}
}
EUVIMED